UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional paid-in capital	Retained earnings	Accumulated other comprehensive (loss)
Balance, beginning of period (in shares) at Dec. 31, 2023		83,840
Balance, beginning of period at Dec. 31, 2023	$ 353,838	$ 838	$ 379,584	$ (8,705)	$ (17,879)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for stock compensation plans (in shares)		1,139
Issuance of common stock for stock compensation plans	18,656	$ 12	18,644
Issuance of common stock under the employee stock purchase plan (in shares)		32
Issuance of common stock under the employee stock purchase plan	1,758		1,758
Stock-based compensation	34,781		34,781
Cash dividends declared	(2,550)		(2,550)
Other comprehensive income (loss)	(4,173)				(4,173)
Net income (loss)	(12,124)			(12,124)
Balance, end of period (in shares) at Mar. 31, 2024		85,011
Balance, end of period at Mar. 31, 2024	$ 390,186	$ 850	432,217	(20,829)	(22,052)
Balance, beginning of period (in shares) at Dec. 31, 2024	86,112	86,112
Balance, beginning of period at Dec. 31, 2024	$ 585,480	$ 861	526,963	87,901	(30,245)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchase of common stock (in shares)	(1,500)
Repurchase of common stock		$ (118,700)
Issuance of common stock for stock compensation plans (in shares)		878
Issuance of common stock for stock compensation plans	$ 9,754	$ 9	9,745
Issuance of common stock under the employee stock purchase plan (in shares)		32
Issuance of common stock under the employee stock purchase plan	1,911	$ 1	1,910
Stock-based compensation	41,425		41,425
Cash dividends declared	(2,567)			(2,567)
Other comprehensive income (loss)	8,548				8,548
Net income (loss)	$ 85,422			85,422
Balance, end of period (in shares) at Mar. 31, 2025	85,562	85,562
Balance, end of period at Mar. 31, 2025	$ 611,269	$ 856	$ 461,354	$ 170,756	$ (21,697)